Nitric oxide decreases the production of inositol phosphates stimulated by angiotensin II and thyrotropin-releasing hormone in anterior pituitary cells

European Journal of Endocrinology

Volumn 148, Issue 1, 2003, Pages 89-97

  Velardez, Miguel O ^a   Benitez, Ariel H ^a   Cabilla, Jimena P ^a   Bodo, Cristian C A ^a   Duvilanski, Beatriz H ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; 6 ANILINO 5,8 QUINOLINEQUINONE; 8 BROMO CYCLIC GMP; ANGIOTENSIN; ARACHIDONIC ACID; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; INOSITOL PHOSPHATE; MEMBRANE RECEPTOR; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHOSPHATIDYLINOSITIDE; PROLACTIN; PROTIRELIN; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; HORMONE RELEASE; HYDROLYSIS; HYPOPHYSIS CELL; ION EXCHANGE CHROMATOGRAPHY; MALE; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; RAT STRAIN; REGULATORY MECHANISM; SECOND MESSENGER;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; GUANYLATE CYCLASE; INOSITOL PHOSPHATES; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; PITUITARY GLAND, ANTERIOR; RATS; RATS, WISTAR; THYROTROPIN-RELEASING HORMONE; VASOCONSTRICTOR AGENTS;

EID: 0037266047     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1480089     Document Type: Article

References (53)

1. Wolf G. Nitric oxide and nitric oxide synthase: biology, pathology, localization. Histology and Histopathology 1997 12 251-261.
2. Ceccatelli S, Hulting AL. Zhang X Gustalsson L & Villar M. Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. PNAS 1993 90 11292-11296.
3. Lloyd RV, Jin L, Qian X, Zhang SY & Scheithauer BW. Nitric oxide synthase in the human pituitary gland. American Journal of Pathology 1995 146 86-94.
4. Okere CO, Murata E & Higuchi T. Perivascular localization of nitric oxide synthase in the rat adenobypophysis: potential implications for function and cell-cell interaction. Brain Research 1998 784 337-340.
5. Kato M. Involvement of nitric oxide in growth hormone (GH)-releasing hormone-induced GH secretion in rat pituitary cells. Endocrinology 1992 131 2133-2138.
6. Duvilanski BH, Zambruno C, Setlicovich A, Pisera D. Lasaga M. Díaz MC et al. The role of nitric oxide in the control of prolactin release by adenobypophysis; PNAS 1995 92 170-174.
7. Vankelecom H, Matthys P & Denef C. Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures. Molecular and Cellular Endocrinology 1997 129 157-167.
8. Freeman M, Kanyicska B, Lerant A & Nagy G. Prolactin: structure, function, and regulation of secretion. Physiological Reviews 2000 80 1523-1631.
9. Page RB. The anatomy of the hypothalamo - hypophysial complex. In The Physiology of Reproduction, edn 2, ch 26, pp 1527-1619. Eds E Knobil & J-D Neill. New York: Raven Press Ltd, 1994.
10. Tashjian AHJ, Barowsky NJ & Jensen DK. Thyrotropin releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture. Biochemical and Biophysical Research Communications 197143 516-523.
11. Schramme C & Denef C. Stimulation of prolactin release by angiotensin H in superfused rat anterior pituitary cell aggregates, Neuroendocrinology 1983 36 483-485.
12. Canonico P & MacLeod R. Angiotensin peptides stimulate phosphoinositide breakdown and prolactin release in anterior pituitary cells in culture. Endocrinology 1986 118 233-238.
13. Brenner-Gati L & Gershengorn MC. Effects of thyrotropin- releasing hormone on phosphoinositides and cytoplasmic free calcium in thyrotropic pituitary cells. Endocrinology 1986 118 163-169.
14. Bilezikjian LM, Blount AL & Vale WW. The cellular actions of vasopressin on corticotrophs of the anterior pituitary: resistance to glucocorticoid action. Molecular Endcrinolology 1987 1 451-458.
15. 2+ mobilizing hormones: the case of gonadotropin-releasing hormone. Endocrine Reviews 1990 11 326-353.
16. Mau SE, Witt MR, Bjerrum. OJ, Saermark T & Vilhardt H. Growth hormone releasing hexapeptide (GHRP-6) activates the inositol (1.4,5)-ft-isphosphate/diacylglyceroI pathway in rat anterior pituitary cells. Journal of Receptors and Signal Transduction Research 1995 15 311-323.
17. Duvilanski BH, Velardez MO, Gonzàlez Iglesias A, Theas S, Seilicovich A & Becu-Villalobos D. Nitric oxide donors modify free intracellular calcium levels in rat anterior pituitary cells. Molecular and Cellular Endocrinology 1998 146 19-26.
18. 2+ release in neurosecretory PC-12 cells: Inhibition of phospholipase C activity via cyclic GMP-dependent protein kinase 1. Molecular Pharmacology 1995 47 517-524.
19. Xia. C, Bac, Z. Yne C, Sanborn BM & Liu M. Phosphorylation and regulation of G-protein activated phospholipase C-β3 by cGMP-dependent protein kinases. Journal of Biological Chemistry 2001 276 19770-19777.
20. Komalavilas P & Lincoln TM. Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the Intact rat aorta. Journal of Biological Chemistry 1996 271 21933-21938.
21. Haug LS, Jensen V, Hvalby 0, Walaas SI & Ostvold AC. Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic nucleotide-dependent kinases in vitro and in rat cerebellar slices in situ. Journal of Biological Chemistry 1999 274 7467-7473.
22. Gershengorn MC. Mechanism of thyrotropin releasing hormone stimulation of pituitary hormone secretion. Annual Review of Physiology 1986 48 515-526.
23. Enjalbert A. Bertrand P. Bockaert J. Drouva S & Kordon C. Multiple coupling of neurobormone receptors with ciclic AMP and, inositol phosphate production in anterior pituitary cells. Biochimie 1987 69 271-279.
24. 11. Molecular Endocrinology 1992 6 1673-1681.
25. Ascoli M, Pignataro OP & Segaloff DL. The inositol. phosphate/ diacylglycerol pathway in MA-10 Leydig tumor cells. Journal of Biological Chemistry 1989 264 6674-6681.
26. 1 cells. Endocrinology 1991 128 2715-2722.
27. Velardez MO, Ogando D, Franchi AM & Duvilanski BH. Role of nitric oxide in the metabolism of arachidonic acid in the rat anterior pituitary gland. Molecular and Cellular Endocrinology 2001 172 7-12.
28. Stasch JP Becker CA, Apeler H, Dembowsky K, Feurer A et al. NO-independent regulatory site on soluble guanylate cyclase. Nature 2001410 212-215.
29. Canonico PL, Sortino MA, Speciale C & Scapagnini U. Neurotensin stimulates polyphosphoinositide breakdown and prolactin release in anterior pituitary cells in culture. Molecular and Cellular Endocrinology 1985 42 215-220.
30. Velardez MO, De Laurentils A, Díaz MC, Lasaga M, Pisera D, Seilicovich A et al. Role of phosphodiesterase and protein kinase G on nitric oxide-induced inhibition of prolactin release from the rat anterior pituitary. European Journal of Endocrinology 2000 143 279-284.
31. Duvilanski BH, Zambruno C, Lasaga M, Pisera D & Seilicovich A. Role of nitric oxide/cyclic GMP pathway in the inhibitory effect of GABA and dopamine on prolactin release. Journal of Neuroendocrinology 1996 8 909-913.
32. Moncada. S, Palmer RMJ & Higgs EA. Nitric oxide: physiology pathophysiology and pharmacology. Pharmacological Reviews 199143 109-142.
33. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB Journal 1992 6 3051-3064.
34. Prasad RK, Behrooz A & Ismail-Beigi F. LY-83583 stimulates glucose transporter-l-mediated glucose transport independent of changes in cGMP levels. European Journal of Pharmacology 1999 366 101-109.
35. 11-subunit with cytoskeleton in adrenal glomerulosa cells: role in receptor-effector coupling. Endocrinology 1997 138 3299-3307.
36. -. Neuron 1999 24 461-469.
37. Choi YB, Tenneti L, Le DA, Ortiz J, Bai G, Chen HSV et al. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nature Neuroscience 2000 3 15-21.
38. Castel H & Vaudry H. Nitric oxide directly activates GABA(A) receptor function through a cGMP/protein kinase-independent pathway in frog pituitary melanotrophs. Journal of Neuroendocrinology 2001 13 695-705.
39. Meszaros LG, Minarovic I & Zahradnikova A. Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Letters 1996 380 49-52.
40. Li Z, Chapleau. MW, Bates JN. Bidefeldt K, Lee HC & Abboud FM. Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons. Neuron 1998 20 1039-1049.
41. Estrada C, Gomez C, Martin-Nieto J, De Frutos T, Jimenez A & Villalobo A. Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase. Biochemical Journal 1997 326 369-376.
42. Nguyen BL, Saitoh M & Ware JA. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. American Journal of Physiology 1991261 H1043-111052.
43. 2+ current in rat ventricular myocytes. Journal of Physiology 2001 531 117-130.
44. K,ACh in rat cardiac myocytes. Journal of Physiology 2002 540 411-424.
45. Lander HM, Ogiste JS, Pearce SF, Levi R & Novogrodsky A. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. Journal of Biological Chemistry 1995 270 7017-7020.
46. Lander M Sehajpal PK & Novogrodsky A. Nitric oxide signaling: a possible role for G proteins. Journal of Immunology 1993 151 7182-7187.
47. Mallis RJ, Buss JE & Thomas JA. Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochemical Journal 2001 355 145-153.
48. Shaul PW & Anderson RG. Role of plasmalemmal caveolae in signal transduction. American Journal of Physiology 1998 275 L843-L851.
49. Ishizaka. N, Griendling KK, Lassegue B & Alexander RW. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 1998 32 459-466.
50. Hope HR & Pike LJ. Phosphoinositides and phosphoinositide-utilizing enzymes in detergent-insoluble lipid domains. Molecular Biology of the Cell 1996 7 843-851.
51. Pike LJ & Casey L. Localization and turnover of phosphatidylinositol 4.5-bisphosphate in caveolin-enriched membrane domains. Journal of Biological Chemistry 1996 271 26453-26456.
52. Goligorsky MS, Tsukahara H, Magazine H, Andersen T, Malik A & Bahou W Termination of endothelin signaling: role of nitric oxide. Journal of Cellular Physiology 1994 158 485-494.
53. Li H, Brodsky S, Basco M, Romanov V, De Angelis DA & Goligorsky MS. Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold. Circulation Research 2001 88 229-236.